Milk Thistle (Expanded) for Liver Health

Research suggests that silymarin, the active compound in milk thistle, shows promise for liver health through its ability to modulate key inflammatory pathways, including NF-κB and MAPK signaling, with a 2024 review concluding that it may have broader anti-inflammatory applications beyond liver disease and appears to be well tolerated. However, the available evidence base is limited in scope, consisting here of a mechanistic review focused on theoretical foundations for future clinical research rather than direct human trials demonstrating clear efficacy. A separate 2026 market analysis found that while milk thistle is the most commonly used ingredient in best-selling liver supplement products, the overall scientific evidence supporting such products' liver health claims remains limited and inconclusive, and the authors noted concerns about the reliability of consumer ratings that might otherwise signal effectiveness. Taken together, the research indicates that milk thistle has plausible biological mechanisms worth further investigation, but robust clinical evidence from randomized controlled trials confirming meaningful benefit for human liver health is still lacking.